Published in
Taylor and Francis Group, Leukemia & Lymphoma, 1(60), p. 246-249, 2018
DOI: 10.1080/10428194.2018.1468893
Links
Tools
Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia
Journal article published in 2018 by
Maximilian Stahl,
Michelle DeVeaux,
Pau Montesinos,
Raphaël Itzykson,
Ellen K. Ritchie,
Mikkael A. Sekeres,
John Barnard,
Nikolai A. Podoltsev,
Andrew Brunner,
Rami S. Komrokji,
Vijaya R. Bhatt,
Aref Al-Kali 
,
Thomas Cluzeau,
Valeria Santini ,
Gail J. Roboz
and other authors.
,
Thomas Cluzeau,
Valeria Santini ,
Gail J. Roboz
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 